Puma Biotechnology (PBYI) Receives Media Impact Rating of -0.13 – The Cerbat Gem

Posted: Published on May 29th, 2017

This post was added by Dr P. Richardson


FactsReporter
Puma Biotechnology (PBYI) Receives Media Impact Rating of -0.13
The Cerbat Gem
Puma Biotechnology logo Media stories about Puma Biotechnology (NYSE:PBYI) have trended somewhat negative recently, Alpha One Sentiment reports. The research firm, a subsidiary of Accern, ranks the sentiment of news coverage by reviewing more ...
Brokerages Set Puma Biotechnology Inc (PBYI) Target Price at $68.42BBNS
Is Puma Biotechnology, Inc. (PBYI) a good buy?TopChronicle
Puma Biotechnology, Inc. (NYSE:PBYI) Stock Sees The Needle Move 110.98%Concord Register
FactsReporter -Transcript Daily -Post Analyst -Zacks Investment Research
all 87 news articles »

Continue reading here:
Puma Biotechnology (PBYI) Receives Media Impact Rating of -0.13 - The Cerbat Gem

Related Posts
This entry was posted in Biotechnology. Bookmark the permalink.

Comments are closed.